Kostiukova, N.I., et al. “CYP2C19*2 Gene Variant (G681A, rs4244285) As a Prognostic Marker for the Clinical Course of Multiple Myeloma”. Experimental Oncology, vol. 43, no. 4, May 2023, pp. 336-40, doi:10.32471/exp-oncology.2312-8852.vol-43-no-4.16924.